Curanex shareholders back 1-for-10 to 1-for-50 reverse stock split to meet Nasdaq $1 bid rule

Curanex Pharmaceuticals Inc.

Curanex Pharmaceuticals Inc.

CURX

0.00
  • Curanex Pharmaceuticals’ board adopted resolutions on May 31, 2026, later authorized by majority written consent dated June 11, 2026.
  • Reverse stock split authorized within a 1-for-10 to 1-for-50 range, with the board to set the final ratio and timing.
  • Split framed as a step to regain compliance with Nasdaq’s $1 minimum bid requirement, with an extended deadline of Nov. 2, 2026.
  • 2026 Equity Incentive Plan adopted, reserving up to 5,700,000 common shares for equity awards, subject to adjustments and potential annual increases.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curanex Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-030447), on June 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.